Chromeleon CDS delivers efficiency gains and compliance and data integrity improvements to UK CRO/CMO

Significance of the Topic

Implementing a robust chromatography data management system is critical for pharmaceutical contract research and manufacturing organizations. Centralized data storage, secure audit trails and consistent processing workflows support regulatory compliance, data integrity and laboratory efficiency. By unifying disparate systems, organizations gain transparent oversight, reduce manual errors and accelerate method transfers, all of which contribute to higher quality and lower operational costs.

Study Overview and Objectives

This case study examines the deployment of Thermo Scientific Chromeleon 7 Chromatography Data System (CDS) at Sterling Pharma Solutions. Key objectives included:

• Replacing two separate CDS installations in QC and R&D laboratories
• Enhancing compliance with 21 CFR Part 11, MHRA and FDA requirements
• Streamlining data processing and reporting
• Facilitating seamless method transfer and instrument sharing

Methodology and Instrumentation

Sterling Pharma Solutions evaluated multiple CDS platforms focusing on ease of use, scalability and integration with existing GC and HPLC systems. The selected solution was Chromeleon 7 CDS supporting 58 instruments (25 GCs and 33 HPLCs) across two laboratories. Core components and tools included:

• Chromeleon 7 CDS software for centralized data storage
• Cobra wizard for automated integration parameter optimization
• SmartPeaks Integration Assistant for streamlined peak processing
• Built-in reporting engine using spreadsheet-style templates

Main Results and Discussion

The rollout and subsequent upgrade to version 7.2 proceeded with minimal downtime, backed by on-site Level 1 and Level 2 training and expert support. Key outcomes comprised:

• Improved system stability with virtually no unplanned outages
• Complete electronic raw data adoption, replacing paper as primary records
• Comprehensive, searchable audit trails that track every user and system event
• Rapid method and report version comparison and rollback capability for QA review
• Significant reduction in manual data transcription through automated, product-specific spreadsheet reports
• Enhanced remote visibility of instrument status and performance metrics

Benefits and Practical Applications

By consolidating data and workflows, Sterling Pharma realized:

• Time savings from automated integration and reporting
• Reduction of transcription errors and duplicate checks
• Stronger data integrity aligned with regulatory audits by FDA, MHRA and external customers
• Simplified training for new analysts via intuitive user interface
• Easier method transfer between labs and across projects

Future Trends and Opportunities

Sterling Pharma plans to expand electronic workflows and digital signatures to replace remaining paper steps, moving toward a fully paperless environment. Upcoming initiatives include:

• Implementing eWorkflows to enforce SOP-driven analyses
• Leveraging Chromeleon Extension Pack for method validation templates
• Further integration with laboratory information management systems (LIMS) for real-time KPI tracking

Conclusion

The adoption of Chromeleon 7 CDS has delivered significant efficiency gains, improved compliance and strengthened data integrity at Sterling Pharma Solutions. Centralized data management, powerful audit capabilities and automated processing have streamlined laboratory operations, reduced costs and positioned the organization for future digital transformation.